K. Miner

发表

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.

D. Lacey, I. Sarosi, J. Delaney, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand

B. Kwon, M. Croft, K. Miner, 2000, European journal of immunology.

Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation.

C. Ware, M. Croft, K. Miner, 1999, Journal of immunology.

Differentiation Is Down-Regulated by IL-4 During Th 2 Activated Naive and Th 1-Like CD 4 Cells but Is Expressed on Recently βα

C. Ware, M. Croft, K. Miner, 1999 .

Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma.

M. Croft, K. Miner, 1998, Journal of immunology.

Effector Cells: Role of Autocrine IL-4 and IFN- Generation, Persistence, and Modulation of Th0

M. Croft, K. Miner, 2017 .

Activation of CD4 T cells by somatic transgenesis induces generalized immunity of uncommitted T cells and immunologic memory.

M. Croft, K. Miner, S. Xiong, 1999, Journal of immunology.

Memoryof Uncommitted T Cells and Immunologic Transgenesis Induces Generalized Immunity Activation of CD4 T Cells by Somatic

M. Croft, K. Miner, S. Xiong, 1999 .

Discovery and in Vivo Evaluation of Dual PI3K-beta/delta inhibitors

D. Whittington, Yi Chen, K. Miner, 2012 .

Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.

K. Gunasekaran, H. Hsu, K. Miner, 2019, Clinical and experimental rheumatology.

Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.

M. Croft, K. Miner, S. Joseph, 1997, Journal of immunology.

Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitors.

D. Whittington, Yi Chen, K. Miner, 2012, Journal of medicinal chemistry.

Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.

S. Chmait, K. Miner, Matthew R. Lee, 2010, Bioorganic & medicinal chemistry letters.

A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.

T. Boone, N. Hawkins, M. Stolina, 2012, Clinical and experimental rheumatology.

Augmentation of naive, Th1 and Th2 effector CD4 Responses by IL‐6, IL‐1 and TNF

M. Croft, K. Miner, S. Joseph, 1998, European journal of immunology.

Lymphotoxin αβ Is Expressed on Recently Activated Naive and Th1-Like CD4 Cells but Is Down-Regulated by IL-4 During Th2 Differentiation

C. Ware, M. Croft, K. Miner, 1999, The Journal of Immunology.

Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS.

T. Boone, T. Horan, J. Delaney, 2000, International immunology.

Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation

J. Treanor, T. Boone, Gang Yu, 2000, The Journal of experimental medicine.

Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.

S. Chmait, K. Miner, Matthew R. Lee, 2009, Bioorganic & medicinal chemistry letters.

Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppression.

L. Wienkers, K. Miner, J. G. Slatter, 2012, Biochemical pharmacology.

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Dirk E. Smith, J. Johnston, O. Homann, 2018, bioRxiv.